Pursuant to Regulation 30, 46, Part A, Para A of Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, IOL Chemicals and Pharmaceuticals has informed that the management of the Company will meet with Perpetuity Ventures LLP (Investment management venture fund) on 6th December 2022 through online video conferencing. No unpublished price sensitive information (UPSI) will be shared during the aforesaid meetings. The above information will also be available on the website of the Company: www.iolcp.com.
The above information is a part of company’s filings submitted to BSE.